Results 111 to 120 of about 95,168 (297)
Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?
Since its widespread introduction, the hepatitis B vaccine has become an essential part of infant immunization programmes globally. The vaccine has been particularly important for countries where the incidence of hepatitis B virus-related hepatocellular ...
C John Clements +5 more
doaj +1 more source
Impaired trophoblast Toll-Like Receptor 3 signaling pathway involves in hepatitis B vaccine non- or hypo-response of infants born to HBsAg-positive mothers [PDF]
Lina Wu +9 more
openalex +1 more source
Current methods to control porcine reproductive and respiratory syndrome, a disease affecting pigs, are insufficient and a safer, more effective vaccine is needed. This study describes the design and plant production of a self‐assembling protein nanoparticle vaccine candidate against this disease.
Jordan T. VanderBurgt +5 more
wiley +1 more source
Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia
Stacy Tressler +4 more
openalex +2 more sources
Practical Considerations in Converting from Plasma-Derived to Recombinant Hepatitis B Vaccines [PDF]
Ping‐Ing Lee, Chin‐Yun Lee
openalex +1 more source
Perspectives on Pertussis Prevention
Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley +1 more source
ABSTRACT Aims Understanding the molecular characteristics and genotype distribution of hepatitis B virus (HBV) is essential to elucidate intra and inter community transmission routes, identify cluster cases, and assess clinical implications based on genotype‐specific virulence.
Ko Ko +10 more
wiley +1 more source
Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults [PDF]
Jing Li +11 more
openalex +1 more source
Informal PrEP use in Greece: The long, hard road to formal programmatic implementation
Abstract Objectives Pre‐exposure prophylaxis (PrEP) with antiretroviral drugs (ARVs) is a highly effective HIV prevention strategy. Although the European Medicines Agency approved oral PrEP in 2016 and the World Health Organization (WHO) has since recommended simplified and person‐centred delivery models, implementation remains inconsistent across ...
Konstantinos Protopapas +3 more
wiley +1 more source

